D. E. Shaw & Co., Inc. Collegium Pharmaceutical, Inc Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 199,149 shares of COLL stock, worth $6.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

199,149

Previous 221,505 10.09%

Holding current value

$6.38 Million

Previous $6.82 Million 13.39%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$31.23 - $40.91 $698,177 - $914,583	-22,356 Reduced 10.09%	199,149 $7.73 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $1.62 Million - $2.35 Million	76,353 Added 52.6%	221,505 $6.82 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $711,311 - $813,501	33,505 Added 30.01%	145,152 $3.24 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $695,990 - $793,152	-33,048 Reduced 22.84%	111,647 $2.4 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $2.77 Million - $3.6 Million	120,621 Added 501.04%	144,695 $3.47 Million

Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $24,371 - $35,560	1,510 Added 6.69%	24,074 $558,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $27,889 - $36,260	-1,804 Reduced 7.4%	22,564 $361,000
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $1.52 Million - $2.23 Million	-106,596 Reduced 81.39%	24,368 $432,000
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $200,534 - $262,327	11,659 Added 9.77%	130,964 $2.67 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $1.28 Million - $1.56 Million	73,226 Added 158.91%	119,305 $2.23 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $817,902 - $1.17 Million	46,079 New	46,079 $910,000
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $746,573 - $1.37 Million	-53,749 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $62,306 - $129,503	5,823 Added 12.15%	53,749 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $304,698 - $398,267	29,990 Added 167.21%	47,926 $550,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $1.26 Million - $1.98 Million	-119,081 Reduced 86.91%	17,936 $236,000
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $1.86 Million - $2.56 Million	137,017 New	137,017 $2.07 Million
Q3 2018 Nov 14, 2018	SELL	$14.16 - $24.3 $417,082 - $715,756	-29,455 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $1.75 Million - $2.28 Million	-80,517 Reduced 73.22%	29,455 $703,000
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $2.13 Million - $3.43 Million	-117,300 Reduced 51.61%	109,972 $2.81 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $725,558 - $1.49 Million	78,017 Added 52.27%	227,272 $4.2 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $1.37 Million - $1.79 Million	149,255	149,255 $1.57 Million

Others Institutions Holding COLL

# of Institutions

231

Shares Held

39.5M

Call Options Held

104K

Put Options Held

15.4K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.09B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account